The Washington Post is reporting that FDA Commissioner Scott Gottlieb, M.D. is resigning. Gottlieb had only been in office since May 2017 but has been pushing a number of initiatives across the industries in which the FDA regulates. In November Gottlieb and CDRH Director Jeff Shuren, M.D., released the agency’s action plan to further improve device and patient safety. And in June 2018 he announced an innovation challenge to fight opioid misuse and abuse.

According to the Post article, Gottlieb wants to spend more time with his family, as he has been commuting between Washington and his home in Connecticut on a weekly basis. The article also reports that President Trump did not want Gottlieb to leave his post.